| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1440-1746.2009.05805.X |
| P698 | PubMed publication ID | 19383082 |
| P2093 | author name string | Kwang-Hyub Han | |
| Yoshiyuki Ueno | |||
| Henry Lik-Yuen Chan | |||
| Deepak Amarapurkar | |||
| Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma | |||
| P2860 | cites work | The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 |
| Combined alpha fetoprotein testing and ultrasonography as a screening test for primary liver cancer | Q34504578 | ||
| Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection | Q43037261 | ||
| Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis. | Q53028105 | ||
| P433 | issue | 6 | |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 955-961 | |
| P577 | publication date | 2009-03-11 | |
| P1433 | published in | Journal of Gastroenterology and Hepatology | Q15764401 |
| P1476 | title | Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region. | |
| P478 | volume | 24 |
| Q36782253 | Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma |
| Q58779802 | Apatinib targets both tumor and endothelial cells in hepatocellular carcinoma |
| Q27003291 | Biomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and china |
| Q40082765 | COST-EFFECTIVE OPTIONS FOR THE PREVENTION AND MANAGEMENT OF GASTROINTESTINAL AND LIVER DISEASE IN THE ASIA-PACIFIC REGION. |
| Q37279232 | Clinical-guide risk prediction of hepatocellular carcinoma development in chronic hepatitis C patients after interferon-based therapy. |
| Q37346665 | Combination of human leukocyte antigen and killer cell immunoglobulin-like receptor genetic background influences the onset age of hepatocellular carcinoma in male patients with hepatitis B virus infection. |
| Q42060589 | Comparison of percutaneous cryosurgery and surgical resection for the treatment of small hepatocellular carcinoma |
| Q36102532 | Does Pay-For-Performance Program Increase Providers Adherence to Guidelines for Managing Hepatitis B and Hepatitis C Virus Infection in Taiwan? |
| Q92684127 | Effect of prophylactic TACE on 5-year survival of patients with hepatocellular carcinoma after hepatectomy |
| Q37105532 | Epidemiology and surveillance of hepatocellular carcinoma |
| Q51018331 | Feasibility of conducting a randomized control trial for liver cancer screening: is a randomized controlled trial for liver cancer screening feasible or still needed? |
| Q92004983 | Ganji Formulation for Patients with Hepatocellular Carcinoma Who Have Undergone Surgery: A Multicenter, Randomized, Double-Blind, Controlled Trial |
| Q96113313 | Improving B-mode ultrasound diagnostic performance for focal liver lesions using deep learning: A multicentre study |
| Q36745162 | Inhibition of hepatocellular carcinoma by PegIFNα-2a in patients with chronic hepatitis C: a nationwide multicenter cooperative study |
| Q42876514 | Liver Cancer Working Group report. |
| Q30448048 | New paradigm for management of hepatocellular carcinoma by imaging |
| Q42636955 | Non-invasive quantitative imaging of hepatocellular carcinoma growth in mice by micro-CT using liver-targeted iodinated nano-emulsions |
| Q40208312 | Patients with non-viral liver disease have a greater tumor burden and less curative treatment options when diagnosed with hepatocellular carcinoma |
| Q37584690 | Perspectives on using des-γ-carboxyprothrombin (DCP) as a serum biomarker: facilitating early detection of hepatocellular carcinoma in China |
| Q49637785 | Prediction of long-term survival rates in patients undergoing curative resection for solitary hepatocellular carcinoma |
| Q34486689 | Prevalence of hepatitis B virus (HBV) infection among Hmong immigrants in the San Joaquin Valley |
| Q53271003 | Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization. |
| Q34826014 | Role of surveillance in prevention of hepatocellular carcinoma |
| Q37989160 | Role of the multidisciplinary team in the diagnosis and treatment of hepatocellular carcinoma |
| Q92798401 | Serum Biomarkers AFP, CEA and CA19-9 Combined Detection for Early Diagnosis of Hepatocellular Carcinoma |
| Q37725466 | Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma |
| Q28085015 | Targeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patients |
| Q34826535 | The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations |
| Q37725272 | Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma |
Search more.